Literature DB >> 25613300

Primary sellar melanocytic tumor mimicking hemorrhagic pituitary macroadenoma: Case report and literature review.

Heng-Jun Zhou1, Ren-Ya Zhan, Yue-Hui Ma, Fei Cao, Xiu-Jue Zheng.   

Abstract

Primary melanocytic tumors of the central nervous system (CNS) are rare lesions, but primary sellar tumors are rarer. Only 10 cases have been reported, and they are often misdiagnosed as pituitary macroadenoma. We report the case of a 54-year-old Chinese man who developed progressive bitemporal hemianopsia and visual loss. Magnetic resonance imaging (MRI) revealed an intrasellar and suprasellar clouded lesion adhering to the optic chiasm, hypothalamus, and hypophyseal stalk that was suspected of being a hemorrhagic pituitary macroadenoma. Because of the atypically giant, hemorrhagic, and upward-growing lesion, an initial trans-sphenoidal approach failed, and subsequent transfrontal craniotomy was adopted to achieve macroscopically complete resection. Histopathologic findings revealed a benign melanocytic tumor. Despite an extensive search, no other primary or secondary site was found. Considering the relatively benign lesion, effective surgery, and potential significant consequences of radiotherapy, the patient received no further treatment and is still alive at the 7-year follow-up. Primary sellar melanocytic tumors are exceptional lesions that are difficult to diagnose before operating and/or obtaining pathological findings. The pathological classification and extent of surgical resection may play a key role in the prognosis. Once this type of lesion is suspected, the transfrontal approach may achieve preferable exposure and resection. Complete surgical resection may be sufficient for relatively benign lesions; otherwise, stereotactic fractionated radiotherapy is indicated. More cases should be reported to improve the treatment strategy.

Entities:  

Keywords:  melanocytic tumor; pituitary macroadenoma; primary; sellar; transfrontal

Mesh:

Year:  2015        PMID: 25613300     DOI: 10.3109/02688697.2014.967752

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  2 in total

Review 1.  Primary sellar melanocytoma: pathological, clinical and treatment review.

Authors:  L Albano; M Losa; L R Barzaghi; G Spatola; P Panni; M R Terreni; P Mortini
Journal:  J Endocrinol Invest       Date:  2019-12-03       Impact factor: 4.256

2.  Suprasellar Melanocytoma with Leptomeningeal Seeding: An Aggressive Clinical Course for a Histologically Benign Tumor.

Authors:  Imen Maaloul; Marwa Moussaoui; Ameni Salah; Wiem Feki; Hela Fourati; Nadia Charfi; Zeineb Mnif
Journal:  Case Rep Radiol       Date:  2021-10-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.